So if we apply the same PE multiple that CSL is trading at now of around 40, and I don't see why not, then that doubles the share price target to around $300/share. The only question is - how many years before we get there? How long do we expect to get through PhIII trials on all 4 treatments of 2591, and approved and marketed and achieving significant global market penetration? 10 years or so?
Share Price, page-8582
-
- There are more pages in this discussion • 2,452 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.01 |
Change
-1.640(8.79%) |
Mkt cap ! $2.174B | |||
| Open | High | Low | Value | Volume |
| $18.15 | $18.18 | $16.87 | $19.94M | 1.159M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5090 | $17.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.10 | 995 | 1 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |